Serial No. 108-20: SARS: Assessment, Outlook, and Lessons Learned: Hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives One Hundred Eighth Congress, First Session, May 7, 2003   [open pdf - 1MB]

Serial No. 108-20: The main purpose of this hearing is "the clear need to continue our vigilance in the fight against SARS to determine whether we are appropriately prepared for any possible SARS upsurge, especially next winter, and to identify where we might improve public health response for future deadly infectious disease outbreaks or bioterrorism attacks. Is SARS a harbinger of the eventual pandemic the disease experts warn we must be prepared to face? It certainly has focused our attention on broader questions of preparedness which at, present fortunately, have not been put to the test. How would we handle large infection rates or isolate and treat infected people? Is our hospitalization infrastructure prepared? Do public health laws measure up to the realities of the day? And what about gaps in international and local surveillance? Will we be able to develop vaccines and other treatments? Do we have the resources? Are we proceeding now to enhance our overall ability to battle infectious outbreaks?" The panel of witnesses at this hearing provide authoritative information on the actions taken in response to SARS and related planning for future outbreaks. Testimony, statements and additional materials submitted for the record include those of the following persons: Georges C. Benjamin, Barry R. Bloom, Denis R. Burger, Robert J. Capetola, Anthony S. Fauci, Paul H. Fischer, Julie L. Gerberding, Jerome M. Hauer, Janet Heinrich, James G. Hodge, Jr., Karin Kerby, Nils Lonberg, Murray Lumpkin, Jared N. Schwartz, and John M. Brenna. An archived webcast of this hearing is available at: http://energycommerce.house.gov/108/Hearings/05072003hearing917/hearing.htm

Report Number:
Serial No. 108-20
Public Domain
Media Type:
Help with citations